SCHEMBL29173644

SCHEMBL29173644

CNc1nc(Nc2cc(C)nc(OCCOC)c2)c(C(=O)OC)nc1-c1cncc2c1ncn2C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30206269 1.00 — —
SCHEMBL24944445 0.93 SYK (0.31) —
SCHEMBL30205684 0.93 SYK (0.31) —
SCHEMBL29173474 0.90 HPGD (0.32) —
SCHEMBL30205968 0.90 HPGD (0.32) —
SCHEMBL29173540 0.86 SYK (0.36) —
SCHEMBL30206169 0.86 SYK (0.36) —
SCHEMBL31195396 0.85 SYK (0.31) —
SCHEMBL24944179 0.84 LRRK2 (0.33) —
SCHEMBL30205755 0.84 LRRK2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
Send feedback